Semaglutide FAQs

The Semaglutide Treatment Effect in People With Obesity (STEP) trials have shown the efficacy of Semaglutide for the treatment of obesity. In large RCTs, patients receiving Semaglutide, 2.4 mg, lost a mean of 6% of their weight by week 12 and 12% of their weight by week 28.

Semaglutide is effective in clinical trials for weight loss and improved overall health. Each individual’s body responds differently, though, so it’s important to meet with our providers for consultation to determine if you are eligible to join the program.

Semaglutide is generally considered safe when taken as directed. As with any medication, there may be risks and side effects such as heartburn/reflux, nausea, constipation, GI disturbances, fatigue, allergic reactions, thyroid conditions, or low blood sugar among others. All of this can be discussed with your provider during your consultation visit. It is also important to notify your provider of any medical conditions and/or relevant family history.

Semaglutide for weight loss is not covered by insurance. It is a self-pay program.

Semaglutide can only be obtain with a prescription from a doctor.

The cost of Semaglutide can vary depending on your dosage and the specific details of your treatment plan. Our team at About Women Ob/Gyn will work with you to determine the cost.